Psychiatrists' Claim on «Pharmacological Restraint» in Mental Health Bill Criticized by TD
Liam Quaide TD criticized the College of Psychiatrists of Ireland's denial of «pharmacological restraint,» arguing its inclusion in the Mental Health Bill is vital. He emphasized that medication can be used coercively, requiring regulation and oversight, a view supported by international bodies and Mental Health Reform.
The College of Psychiatrists of Ireland's claim that «pharmacological restraint» is «highly offensive» and «does not exist» is extraordinary. This dismisses the experiences of individuals who found medication used coercively or over-sedatingly, which can be profoundly traumatic and worsen distress.
Including pharmacological restraint in the Mental Health Bill is crucial as medication can be used restrictively, requiring strict monitoring. Denying this lacks credibility. The UN Committee on the Rights of Persons with Disabilities, the European Committee for the Prevention of Torture, the Irish Human Rights and Equality Commission, and Mental Health Reform advocate for its clear regulation.
Pharmacological restraint is already recognized and regulated in England, Scotland, and Wales. The World Psychiatric Association's 2023 statement also identified it as a form of restraint. Mental Health Reform welcomed its formal recognition in the Bill but noted the proposed definition might be too narrow.
An intention-based definition is insufficient; medication given for treatment but resulting in behavioral control, restricted movement, or disengagement is still a concern. The Bill should ensure meaningful recognition, a robust definition, and a strong code of practice to address less visible coercion, including over-sedation and misuse of «as required» medication. This highlights the need for legislative reform and external oversight.